Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Phathom Pharmaceuticals (PHAT) Revenue: 2018-2024

Historic Revenue for Phathom Pharmaceuticals (PHAT) over the last 7 years, with Dec 2024 value amounting to $55.3 million.

  • Phathom Pharmaceuticals' Revenue rose 202.74% to $49.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $147.2 million, marking a year-over-year increase of 460.30%. This contributed to the annual value of $55.3 million for FY2024, which is 8001.47% up from last year.
  • According to the latest figures from FY2024, Phathom Pharmaceuticals' Revenue is $55.3 million, which was up 8,001.47% from $682,000 recorded in FY2023.
  • In the past 5 years, Phathom Pharmaceuticals' Revenue ranged from a high of $55.3 million in FY2024 and a low of -$27.3 million during FY2022.
  • Its 3-year average for Revenue is $9.5 million, with a median of $682,000 in 2023.
  • Per our database at Business Quant, Phathom Pharmaceuticals' Revenue plummeted by 302.25% in 2022 and then soared by 8,001.47% in 2024.
  • Over the past 5 years, Phathom Pharmaceuticals' Revenue (Yearly) stood at -$4.6 million in 2020, then tumbled by 48.18% to -$6.8 million in 2021, then tumbled by 302.25% to -$27.3 million in 2022, then surged by 102.50% to $682,000 in 2023, then surged by 8,001.47% to $55.3 million in 2024.